Thomas Halusa

Thomas Halusa is an accomplished executive with extensive experience in the healthcare and business development sectors. Currently serving as Chief Executive Officer and Chief Transformation Officer at Innoquest Diagnostics since February 2022, Thomas previously held the role of Group Head of Regional Business Development at Pathology Asia Holdings Pte Ltd from March 2020 to February 2022. At Siloam Hospitals Group, Thomas contributed as Head of Strategy, Growth and Operational Excellence from February 2019 to March 2020 and as Head of Strategic Pricing and Market Analysis from August 2013 to February 2018. Additional roles include leadership positions at MRCCC and various internships, including a research internship at The Brookings Institution. Thomas holds a Master of Science in International Business from Georgetown University and a Bachelor of Arts in Classical Studies from Newcastle University.